TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile …
Over the last 12 months, insiders at TELA Bio, Inc. have bought $519,598 and sold $2.02M worth of TELA Bio, Inc. stock.
On average, over the past 5 years, insiders at TELA Bio, Inc. have bought $13.99M and sold $1.54M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Cuca Roberto (COO and CFO) — $569,811. KOBLISH ANTONY (Chief Executive Officer) — $249,974. Talmo Paul (Chief Technology Officer) — $50,000.
The last purchase of 88,888 shares for transaction amount of $199,998 was made by KOBLISH ANTONY (Chief Executive Officer) on 2024‑10‑24.
2024-10-24 | Chief Executive Officer | 88,888 0.325% | $2.25 | $199,998 | 0.00% | |||
2024-10-24 | COO and CFO | 64,444 0.2356% | $2.25 | $144,999 | 0.00% | |||
2024-10-24 | Chief Technology Officer | 22,222 0.0813% | $2.25 | $50,000 | 0.00% | |||
2024-10-24 | Chief Commercial Officer | 6,666 0.0244% | $2.25 | $14,999 | 0.00% | |||
2024-07-02 | Sale | 10 percent owner | 36,600 0.1299% | $4.54 | $166,164 | 0.00% | ||
2024-07-01 | Sale | 10 percent owner | 13,700 0.0501% | $4.68 | $64,116 | 0.00% | ||
2024-06-28 | Sale | 10 percent owner | 378,000 1.4002% | $4.74 | $1.79M | 0.00% | ||
2023-12-05 | Chief Business Officer | 2,600 0.011% | $5.65 | $14,688 | -0.37% | |||
2023-11-14 | Chief Executive Officer | 11,000 0.0454% | $4.54 | $49,976 | +16.70% | |||
2023-11-14 | COO and CFO | 10,000 0.0408% | $4.49 | $44,938 | +16.70% | |||
2023-04-21 | Sale | 10 percent owner | 27,700 0.1432% | $9.41 | $260,657 | -24.97% | ||
2023-04-20 | Sale | 10 percent owner | 28,300 0.1502% | $9.43 | $266,869 | -22.89% | ||
2023-04-19 | Sale | 10 percent owner | 136,000 0.7142% | $9.30 | $1.26M | -22.43% | ||
2022-11-03 | director | 20,262 0.1236% | $7.81 | $158,285 | +26.43% | |||
2022-10-11 | director | 16,000 0.0971% | $8.00 | $128,000 | +22.84% | |||
2022-08-17 | 500,000 2.8654% | $8.00 | $4M | +19.45% | ||||
2022-08-16 | 15,000 0.0881% | $8.00 | $120,000 | +22.39% | ||||
2022-08-10 | 11,500 0.0684% | $8.52 | $98,006 | +16.37% | ||||
2022-08-01 | 10 percent owner | 4,979 0.0296% | $7.96 | $39,632 | +24.38% | |||
2022-07-22 | 5,000 0.0299% | $8.02 | $40,105 | +24.06% |
ORBIMED ADVISORS LLC | 10 percent owner | 2407242 6.5568% | $3.01 | 1 | 6 | +2.92% |
KOBLISH ANTONY | Chief Executive Officer | 458897 1.2499% | $3.01 | 2 | 0 | |
Cuca Roberto | COO and CFO | 155388 0.4232% | $3.01 | 7 | 0 | <0.0001% |
Talmo Paul | Chief Technology Officer | 91082 0.2481% | $3.01 | 1 | 0 | |
Firestone Gregory A. | Chief Commercial Officer | 57279 0.156% | $3.01 | 2 | 0 |
Essex Woodlands Management Inc | $23.31M | 16.67 | 4.11M | 0% | +$0 | 6.78 | |
OrbiMed | $16.08M | 11.5 | 2.84M | 0% | +$0 | 0.12 | |
First Light Asset Management | $15.62M | 11.17 | 2.75M | +7.8% | +$1.13M | 1.32 | |
Aigh Capital Management Llc | $8.02M | 5.74 | 1.42M | +2.71% | +$211,547.70 | 4.59 | |
Nantahala Capital Management Llc | $6.22M | 4.45 | 1.1M | 0% | +$0 | 0.29 |